Centaurus Financial’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-662
Closed -$142K 821
2024
Q1
$142K Sell
662
-37
-5% -$7.25K 0.01% 693
2023
Q4
$142K Hold
699
0.01% 672
2023
Q3
$139K Hold
699
0.01% 651
2023
Q2
$227K Sell
699
-23
-3% -$6.57K 0.02% 531
2023
Q1
$169K Buy
722
+23
+3% +$5.81K 0.01% 710
2022
Q4
$176K Sell
699
-196
-22% -$41.8K 0.02% 645
2022
Q3
$159K Buy
895
+29
+3% +$5.83K 0.02% 681
2022
Q2
$158K Hold
866
0.02% 697
2022
Q1
$222K Hold
866
0.02% 635
2021
Q4
$199K Hold
866
0.02% 682
2021
Q3
$202K Sell
866
-3
-0.3% -$626 0.02% 648
2021
Q2
$168K Hold
869
0.01% 721
2021
Q1
$180K Sell
869
-75
-8% -$15.9K 0.02% 628
2020
Q4
$178K Sell
944
-116
-11% -$19K 0.02% 585
2020
Q3
$137K Sell
1,060
-186
-15% -$20.5K 0.02% 534
2020
Q2
$108K Buy
+1,246
New +$95.8K 0.02% 580

Other funds holding INSP

Centaurus Financial's INSP Position: Q2 2024 in Review

Centaurus Financial sold out of Inspire Medical Systems (INSP) in Q2 2024, closing a stake of 662 shares — an estimated $142K sold.

Centaurus Financial first reported a position in INSP in Q2 2020 and held it in 16 quarters. The position peaked at $227K in Q2 2023. 325 funds tracked by Wall St. Rank hold INSP as of Q2 2024.

  • Centaurus Financial reported no remaining Inspire Medical Systems position as of Q2 2024 after selling out during the quarter.
  • Centaurus Financial sold 662 Inspire Medical Systems shares in Q2 2024, an estimated $142K.
  • Centaurus Financial first reported a position in Inspire Medical Systems in Q2 2020 and held it in 16 quarters.
  • Centaurus Financial's Inspire Medical Systems position peaked at $227K in Q2 2023.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2024.

Based on Centaurus Financial's 13F filing for Q2 2024, filed 23 Sep 2024.